Expression of tight junction proteins between brain microvascular endothelial cells (BMECs) of the blood-brain barrier (BBB) is lost during development of human immunodeficiency virus (HIV) encephalitis (HIVE). Although many studies have focused on the strains of virus that induce neurological sequelae or on the macrophages/microglia that are associated with development of encephalitis, the molecular signaling pathways within the BMECs involved have yet to be resolved. We have previously shown that there is activation and disruption of an in vitro BBB model using lentivirus-infected CEMx174 cells. We and others have shown similar disruption in vivo. Therefore, it was of interest to determine if the presence of infected cells could disrupt intact cerebral microvessels immediately ex vivo, and if so, which signaling pathways were involved. The present data demonstrate that disruption of tight junctions between BMECs is mediated through activation of focal adhesion kinase (FAK) by phosphorylation at TYR-397. Inhibition of FAK activation is sufficient to prevent tight junction disruption. Thus, it may be possible to inhibit the development of HIVE by using inhibitors of FAK. Journal of NeuroVirology (2009) 15, 312Á323.
Introduction
Human immunodeficiency virus (HIV) and the closely related virus simian immunodeficiency virus (SIV) cause central nervous system (CNS) disease in approximately one third of infected individuals, including development of encephalitis (Baskin et al, 1988; Lackner et al, 1989 Lackner et al, , 1991 . Although breakdown of blood-brain barrier (BBB) occurs (Luabeya et al, 2000; MacLean et al, 2005; Mankowski et al, 1999) , relatively little is known of when this begins or of the molecular mechanisms associated with the breakdown. Questions regarding molecular signaling events and viral entry can be most readily answered using ex vivo and in vitro studies, because the precise timing of viral entry varies with host and virus. (Hirsch et al, 1997; Mankowski et al, 1994; Orandle et al, 2001; Westmoreland et al, 1998) .
We developed in vitro and ex vivo models of the BBB suitable for studies of SIV encephalitis (MacLean et al, 2002 (MacLean et al, , 2005 (MacLean et al, , 2004a . These studies showed that there was a requirement for SIVinfected cells to cross an in vitro BBB model to activate both the brain microvascular endothelial cells (BMECs) and astrocytes in a manner similar to that observed in vivo (MacLean et al, 2004a,b) . Using immediately ex vivo microvessels obtained from encephalitic brains, we demonstrated considerably lower levels of ZO-1 protein compared with microvessels obtained from control brains (MacLean et al, 2005) . Here, we use our ex vivo model of the BBB to begin examining the molecular events associated with breakdown of the BBB.
Activation and translocation of focal adhesion kinase (FAK) has been reported to be a mechanism by which increased endothelial permeability occurs (Avraham et al, 2004) . FAK is required for efficient angiogenesis and remodeling, with data suggesting that without FAK, there can be no reorganization of junction proteins along actin filaments to form junctions (Ilic et al, 2004; Linseman et al, 1999; Sawada and Sheetz, 2002) . Therefore, it would be anticipated that FAK is involved in reorganization or disruption of tight junctions. The tyrosine at position 397 is a candidate phospho-specific site of FAK activation associated with tight junction disruption events.
Phosphorylation of FAK leads to activation of the kinase and thus decreases the number of focal adhesions 'beneath' cells (Brown et al, 2005; Ilic et al, 2004; Usatyuk and Natarajan, 2005) . Concomitant with this, there are decreased adhesions 'between' BMECs (tight and adherens junctions), leading to increased permeability , which is linked to development of encephalitis (Avraham et al, 2004; Dallasta et al, 1999; Kim et al, 2003; Selmaj, 1996) . It has been shown in clinical SIV encephalitis (SIVE) cases that ZO-1 decreases following tight junction disruption in subcortical white matter and to a lesser extent in gray matter (Dallasta et al, 1999) . ZO-1 has also been shown to decrease in vitro following transmigration of HIV positive leukocytes (Eugenin et al, 2006) .
We sought to determine if activation of the FAK pathway diminishes the expression of ZO-1 and if SIV-infected monocyte/macrophages are required for development of encephalitis by disruption of tight and adherens junctions in a FAK-dependent manner. We hope this will lead to new therapeutic targets because highly active antiretroviral therapy (HAART) alone does not decrease the prevalence of encephalitis or peripheral neuropathies (Kusdra et al, 2002; Shiramizu et al, 2005) .
Results

Preparation of microvessels
Isolated control microvessels typically appear as shown in Figure 1 in lengths or small networks of up to several hundred microns. Nuclei of endothelial cells are evident along the lengths of these control microvessels, with hematoxylin staining at low magnification ( Figure 1A ) and at higher magnification ( Figure 1B) .
In order to determine that our stimulus cells (CEMx174 or primary macrophages) were productively infected with SIVmac251, we combined in situ hybridization and immunohistochemistry. We stained macrophages infected with SIV (in red) and control macrophages (stained with HAM56, green) to verify the level of infectivity. No detectable SIV RNA was found in control cultures ( Figure 1C ). Effectively all (90%) bone marrowÁderived macrophages were productively infected with SIVmac251 as shown with in situ hybridization 72 h after infection ( Figure 1D ). As with other studies, generally 10% of CEMx174 cells were productively infected (red) with SIVmac251 (Sabine Lange, personal communication; in situ hybridization of cytospins, Figure 1E ).
Lentiviral-induced disruption of ZO-1 patterning
To investigate BBB disruption following exposure to SIV-infected cells, we examined changes in the expression of tight junction protein ZO-1 in microvessels incubated with control CEMx174 cells and SIVmac251-infected CEMx174 cells (n 020 each data point, both groups). Normal microvessels incubated in the presence of uninfected CEMx174 cells, demonstrate a linear ''zipper'' pattern of ZO-1 expression, with rings of protein expression between BMECs (Figure 2A ). When brain microvessels were incubated in the presence of SIVmac251-infected CEMx174 cells, a loss of ZO-1 expression was observed along the length of microvessels during the first 8 h of incubation. At 4 h, these changes can be observed ( Figure 2B ). Freshly isolated microvessels express a uniform ''zipper'' expression of ZO-1 protein ( Figure 2C ).
Statistical evaluation of decreased ZO-1 intensity When fluorescence was quantified in these microvessels over time ( Figure 2D ), A significant decrease in ZO-1 intensity in SIV-exposed microvessels is evident at the 8-h time point versus controls (P B .01). Although there is a trend toward increased ZO-1 fluorescence in the control group, this effect is not statistically significant over 8 h (P0.363). Because maintenance of tight junctions is dependent on the proper organization of junctional scaffolding proteins such as ZO-1, it would be anticipated that there would be disruption of the BBB resulting from this altered ZO-1 patterning.
Focal adhesion kinase expression precedes reduction of ZO-1 expression To establish if a change in ZO-1 expression is linked to expression of focal adhesion kinase (FAK), microvessels were incubated and stained as above (n020 each data point, each group). Freshly extracted microvessels from control macaques expressed undetectable (or barely detectable) levels of FAK after incubation with CEMx174 cells for 1, 2, 4, or 6 h ( Figure 3A to D, respectively). This suggests that the presence of CEMx174 cells in proximity to the BBB is not sufficient in and of itself for activation of FAK.
We then investigated the effects of incubation of microvessels with SIVmac251-infected CEMx174 cells as above ( Figure 3E to H, respectively). Following incubation of these microvessels with SIVinfected CEMx174 cells, FAK expression patterns changed. After a 1-h incubation, SIV treated microvessels began to express FAK in a similar pattern to ZO-1 expression ( Figure 3E ). Following incubation of the microvessels for 2 h with SIVmac251-infected CEMx174 cells, the expression of FAK increased further and appeared to be continuous along the length of the microvessels ( Figure 3F ). At 4-and 6-h time points, the level of FAK expression decreases, with the pattern of FAK immunostaining most closely resembling the staining seen at 1-h points ( Figure 3G and H, respectively).
Analysis of mean fluorescent intensity in the green channel (FAK immunostaining) indicated transient increases of FAK expression at the 2-and 4-h time points ( Figure 3I ). At the 2-h time point, there is a significant 1.44-fold increase in FAK expression (P 5.005, n 020).
The changes in FAK and ZO-1 expression can be viewed concurrently as illustrated in the 3-h incubations shown in Figure 4 , with FAK in green, ZO-1 in red, and nuclei in blue. Figure 4A is a 3-h incubation of control microvessels. Figure 4B is a 3-h incubation of microvessels with noninfected CEMx174 cells and shows little difference from the control. However, the addition of SIV-infected CEMx174 cells for 3 h results in increased FAK, and decreased ZO-1 ( Figure 4C ). 
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Macrophage-induced activation of FAK and disruption of ZO-1 These effects, seen with the CEMx174 cell line were also observed when microvessels were exposed to SIVmac251-infected primary bone marrowÁderived macrophages ( Figure 5 ). Figure 5A shows microvessels incubated with uninfected primary bone marrowÁderived macrophages for 3 h. In Figure  5B , freshly isolated microvessels were incubated with SIVmac251-infected primary macrophages for Using NIH Image v1.62 we determined mean fluorescence intensities of 10-mm lengths of microvessels. We measured along five nonoverlapping sections of each of at least four vessels in areas anticipated to be rich for ZO-1 expression. The graph (D) demonstrates that although there may be an initial loss of expression of ZO-1 in control vessels, there is a steady loss of ZO-1 fluorescence intensity after 2 h incubation with SIV-infected CEMx174 cells. Error bars represent standard errors of the means.
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Figure 3 Expression of focal adhesion kinase (FAK) in freshly isolated microvessels. Microvessels incubated with control CEMx174 cells expressed low levels of FAK (green) at time points 1, 2, 4, and 6 h (A to D, respectively). Following 1-h incubation with SIVmac251-infected CEMx174 cells, there was minimally (not significant) increased expression of FAK (E). At 2 h, the expression of FAK was similar to the normal expression of ZO-1 (F). The levels of expression of FAK then begins to wane over the next 4 h (G), returning to basal levels by 6 h (H). As the graph represents (I), FAK expression significantly increases at the 2-h time point when vessels are exposed to SIV (P 0.004), and then subsides to control levels. Determination of specificity of signal transduction pathways To show that the FAK pathway is involved in BBB tight junction regulation in neuroAIDS, we used PAO, a known inhibitor of FAK (Linseman et al, 1999; Retta et al, 1996; Sawada and Sheetz, 2002; Yuan et al, 1998) . Microvessels were incubated in 5 mM PAO for 15 min before incubating with SIVmac251-infected (and control) CEMx174 cells ( Figure 6 ). In the presence of PAO, SIV-infected CEMx174 cells not only did not induce any FAK expression ( Figure 6A ), but there was no loss of ZO-1 expression, indicating a specificity in the signal transduction pathway induced by SIV-infected CEMx174 cells. Similarly, incubation of PAO-treated microvessels with control CEMx174 cells showed no change in ZO-1 expression ( Figure 6B ).
Expression of FAK protein
Total FAK protein in microvessel lysates rapidly increases upon exposure to SIVmac251-infected macrophage supernatant ( Figure 7A ). Additionally, a similar analysis of total FAK protein over time Figure 5 FAK and ZO-1 altered by primary SIV-infected macrophages and macrophage supernatants. Isolated microvessels were incubated for 3 h with bone marrow derived macrophages that were either uninfected (A) or infected with SIVmac251 (B). At 3 h, the control microvessels show strong ZO-1 staining (green) and very little FAK (red). In the SIV-exposed microvessels, FAK is more robust and ZO-1 diminished, with gaps along the length of the vessel. showed an increase following exposure to SIVinfected macrophage supernatant, with up to a 2-fold increase at 2-h incubation ( Figure 7B ). In order to more accurately assess whether our confocal results indicated an actual change in the quantity of activated tight-junction associated FAK, we also probed microvessel Western blots for phosphospecific FAK Tyr-397 protein. When probed for FAK Tyr-397 by Western blotting, vessel lysates that had been incubated with SIV-infected macrophages for 2 h showed increased expression in lane 2 ( Figure 7C ) compared to incubation with uninfected macrophages in lane 1 compared to loading control. Band densitometry at this 2-h time point indicated that FAK Tyr-397 increased by 1.57-fold.
Discussion
Our experiments indicate activation of immediately ex vivo cerebral microvessels following incubation with SIVmac251-infected mononuclear cells that is mediated via phosphorylation of FAK and subsequent alteration in the expression of the tight junction anchorage protein ZO-1. Activation of FAK is rapid, occurring within 2 h, with phosphorylation of tyrosine residue 397.
Encephalitis associated with SIV infection of macaques and HIV infection of humans is characterized by astrocyte and microglia activation paired with productive infection of macrophages and multinucleated giant cells Persidsky et al, 1995) . This is accompanied by activation of the cerebral microvasculature Sasseville et al, 1992 Sasseville et al, , 1994 ). We and others have shown that tight junctions of microvessels are disrupted during terminal AIDS (Andras et al, 2003; MacLean et al, 2005; . By examining ex vivo microvessels, we found that disruption of the BBB, manifested by changes in ZO-1 expression, did not occur at discrete spots (MacLean et al, 2005) . Rather, microvessels obtained from SIVE brains have diminished ZO-1 expression over distances of several dozen microns and multiple cell lengths.
ZO proteins are thought to link occludin/claudins to F-actin filaments via ZO-associated protein.
Decreases in ZO-1 have been correlated with increased permeability of the tight junction, and BBB disruption (Chaudhuri et al, 2008; Kebir et al, 2007) . In macaques with SIV encephalitis, ZO-1 staining in medium-sized vessels becomes patchy or decreased, especially in areas associated with perivascular macrophages or multinucleated giant cells (Luabeya et al, 2000) . Similar results have been produced by evaluating the significant ZO-1 repatterning in small and medium-sized vessels that occurs in HIV encephalitis patients during a postmortem study (Dallasta et al, 1999) . We chose to examine ZO-1 because of its relevance in other studies looking at BBB disruption, and also because it is thought to be the primary component of anchorage sites in common for transmembrane tight junction proteins like junctional adhesion molecules (JAMs), claudins, and occludin. It is therefore likely that the degradation or reorganization of ZO-1 results in tight junction integrity dysregulation.
Recently, Avraham and colleagues have shown that the HIV protein Tat can induce increased phosphorylation of FAK leading to increased endothelial permeability (Avraham et al, 2004) . In addition to Tat, gp120 from HIV has been shown to cause disruption of tight junctions (Avraham et al, 2004; Kanmogne et al, 2005) , leading to vascular dysfunction (Lohmann et al, 2004) . Whether or not Figure 7 Western blot of FAK expression. FAK protein increases transiently when incubated with SIVmac251-infected macrophages. At 60 and 75 min post incubation, FAK increases over control lysates (A). Band densitometry was performed of total FAK/area in a time course of SIVmac251 exposed or nonexposed microvessels subjected to a 4-h time course (B). Total FAK protein in these samples increased at up to 2-fold during the course of the experiment. Expression of FAK397 is increased in microvessels incubated with SIVinfected versus control macrophages (C).
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Tat is free in the extracellular space is still a matter of speculation. Further complicating this issue, purified Tat has been shown to have no effect on ZO-1 or occludin in an in vitro model (Andras et al, 2003) , although ZO-2 and claudins 1 and 5 were diminished. Our studies show that primary bone marrowÁderived macrophages infected with pathogenic SIV can activate FAK in a time course similar to that observed with purified Tat, an event followed by the reorganization of ZO-1 in freshly ex vivo cortical microvessels.
FAK is activated by intracellular tyrosine phosphatases (Leu et al, 2003; Lohmann et al, 2004) . Increased FAK expression was blocked by the addition of the tyrosine phosphatase inhibitor PAO. This would have been expected to maintain the expression of the tight junction protein ZO-1 (Wachtel et al, 1999) , and thus inhibit any increase in vascular permeability (Staddon et al, 1995) . Tyrosine 397 (Tyr-397) is thought to be the primary site of phosphorylation on the n-terminal domain of FAK. Activation of FAK at Tyr-397 is thought to induce further phosphorylation of the protein at Tyr-576 and Tyr-577 by way of positive feedback (Ruest et al, 2000) .
It will be of interest to determine if other tight junction proteins are also affected by FAK activation, or if other tyrosine phosphatase inhibitors are as effective at blocking FAK activation by HIVinfected cells. These data suggest that by inhibiting tyrosine phosphorylation of FAK, we can inhibit mononuclear cell-mediated degradation of BBB junctional components. This could be of importance not only in lentiviral-associated mononuclear infiltration (Potula et al, 2005; Stins et al, 2003) , but also in other neurovascular infections such as those associated with Cryptococcus (Chen et al, 2003) and Borrelia (Ramesh and Philipp, 2005) infections.
Combined, these studies show that HIV-infected mononuclear cells induce activation of the FAK pathway within intact cerebral microvessels and that this activation is dependent on tyrosine phosphatase activity. Selectively targeting FAK activation may lead to new strategies for inhibiting development of acquired immunodeficiency syndrome (AIDS) dementia by preventing breakdown of BBB.
Materials and methods
Culture of virus-infected cells
CEMx174 cells and primary macrophages were used for these studies. CEMx174 cells were a kind donation from Dr. Preston Marx (Tulane National Primate Research Center). Cells were maintained in RPMI (Roswell Park Memorial Institute)-1640 medium containing 10% fetal calf serum. Cultures were subdivided 1:4 once per week. Cultures infected with SIVmac251 (as previously described [MacLean et al, 2004a] ) were grown exactly as the control cultures, with the exception that, upon subculturing, control CEMx174 cells were added to the cultures to a final concentration of 10 6 /ml, ensuring a fresh supply of cells to be infected.
Primary macrophages were isolated from Rhesus macaque (Macaca mulatta) femur bone marrow at necropsy. Briefly, 2 ml bone marrow was vortexed and centrifuged at 400)g at 258C (Fisher Marathon 5000R centrifuge). Supernatant was decanted and the pellet resuspended in phosphate-buffered saline (PBS) (Gibco). This cell suspension was filtered (110-mm filter), and the filtrate consisting of enriched macrophages was plated. When nearly confluent, some plates were kept as controls, whereas the remainder were infected with SIVmac251 (by the same procedure as Gautam et al [2007] ). Macrophages were grown in Iscove's modified Dulbecco's medium (Mediatech) and supplemented with 10% heat-inactivated fetal bovine serum (Gibco) and 1% penicillin/streptomycin (BioWhittaker). Macrophages were removed from culture flasks using trypsin/versene, and resuspended at a final concentration of 10 6 /ml. Cultures were routinely greater than 95% macrophages by immunohistochemistry with the macrophage marker HAM 56. Primary cells were determined to be productively infected by in situ hybridization for SIV RNA. Sense probe was used as a control.
Extraction of microvessels Microvessels were extracted from frontal cortices collected from normal Rhesus macaques at scheduled necropsy, as previously described (MacLean et al, 2005) . In brief, meninges and contaminating vessels were removed before mincing the cortices and passing through a 320-mm nylon filter. The filtrate was collected and poured through a 110-mm nylon filter and rinsed until sterile PBS passed through the filter clear. Microvessels were collected from the filter by washing with M199 medium (Mediatech) into 50-ml tubes. The microvessels were centrifuged at 1000 rpm for 6 min (Fisher Marathon 5000R centrifuge) and the supernatant decanted. Microvessels were then resuspended in M199 medium containing 10% fetal calf serum. In total, the microvessel yield from 1 g of cortical tissue was resuspended in 15 ml of medium.
Incubation of microvessels with infected cells and supernatants
Slides were pretreated with poly-l-lysine (50 mg/ml in PBS) for 30 min to facilitate adhesion. Freshly prepared microvessels (1 g of initial cortical tissue/ 15 ml medium) were resuspended in medium containing SIV-infected and control CEMx174 cells, macrophages (10 6 /ml) or their supernatants and were incubated on slides for 0, 1, 2, 4, 6, or 8 h at 378C. Two slides were prepared per data point. A FAK up-regulation and ZO-1 disruption in SIV infection final ratio of approximately 15:1 (infected cells: BMEC) was used for all experiments. If pretreating with phenylarsine oxide (PAO), a 15-min preincubation occurred prior to microvessel exposure to macrophages or CEMx174 cells. Slides were fixed with 2% paraformaldehyde and stored at 48C overnight in PBS prior to immunohistochemical staining.
Confocal microscopy
Microvessels on slides were permeabilized with PBS containing 1% bovine serum albumin and 0.1% Triton-X-100 (Sigma) for 10 min. Following permeabilization, slides were blocked for 1 h with normal goat serum (Sigma) and rinsed with PBS containing 1% bovine serum albumin (BSA) (Sigma). Slides were stained for confocal imaging using primary antibodies to ZO-1 and FAK at concentrations outlined in Table 1 overnight at 48C.
Slides were thoroughly washed and mounted using MOWIOL 4-88/Glycerol/DABCO (Calbiochem, La Jolla/Sigma/Sigma). Confocal microscopy was performed using a Leica TCS SP2 confocal microscope equipped with three lasers (Leica Microsystems, Exton, PA) to collect up to three channels simultaneously. Forty optical slices were collected at 512 )512-pixel resolution and captured with Leica Confocal Software (Leica Microsystems). Each individual slice represented a thickness of 0.4 mm.
Secondary antibodies used include goat antirabbit (heavy and light chains) conjugated to Alexa 488, appearing green (Molecular Probes, Eugene, OR); goat anti-mouse (immunoglobulin G1 [IgG1]) conjugated to Alexa 568, appearing red (Molecular Probes); and To-Pro3 iodide was used as a nuclear stain, appearing blue (Molecular Probes). Secondary antibodies were applied at a concentration of 1:1000 for 1 h at 378C. To-Pro3 was applied for 10 min.
Image analysis, quantification, and statistics Each channel of the confocal images (color) was analyzed using NIH Image (v. 1.38) to determine mean fluorescence intensity of target proteins along junctional ''zippers'' of microvessels. This is achieved by averaging a ''stack'' of images, and taking a snapshot of this mean image. Each individual image is scanned 3 times and background is automatically subtracted. Images were collected with a 63 )objective and 2 )digital zoom. From these averaged snapshots, we manually traced the microvessels with NIH Image drawing tools, and measured the pixel intensity/traced area or mean pixel intensity. The data were plotted using Microsoft Excel. Statistical significance and P values were determined by using Student's t test (P values B.05 are considered significant and are noted by an asterisk). This process allows for a standardized, reproducible, and quantitative analysis of fluorescence intensity.
Inhibition of FAK phosphorylation
Phosphorylation of tyrosine residues has been shown to activate focal adhesion kinase (Linseman et al, 1999; Sawada and Sheetz, 2002) . There are no specific inhibitors of FAK readily available at this time. To begin to address this issue, we used an inhibitor of tyrosine phosphorylation, phenylarsine oxide (PAO) to inhibit the activation of FAK (Linseman et al, 1999) by preincubating microvessels with 5 mM PAO for 15 min before the addition of control or SIV-infected CEMx174 cells.
Determination of post-translational control
To determine if FAK is phosphorylated, and hence activated, during incubation with SIV-infected cells, relative levels of phosphorylated FAK were measured using Western blots of microvessel lysates. Microvessels were incubated with SIV-infected or control cells (either CEMx174 or primary macrophages) for the indicated times. Microvessels were then rinsed on top of cell filters (70-mm pore) to remove any SIV-infected CEMx174 cells or macrophages. Samples were protected from proteases and phosphatases using Halt Inhibitor cocktail (Pierce, Rockford, IL) and were prepared on ice. Initial lysis used a Triton X-100 detergent base containing 10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 300 mM sucrose and 0.5% Triton X-100. The Tritoninsoluble pellet was gently washed twice with Trisbuffered saline (containing Halt inhibitor cocktail) and extracted using a RIPA detergent containing 10 mM Tris-HCl, 140 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and the same protease inhibitors as above. 
Immunoprecipitation
Tissue lysates were precleared with 50 ml normal rabbit serum/ml of lysates and incubated 1 h on ice. One hundred microliters of protein AÁcoupled Sepharose beads (Abcam) were then added. The lysate-bead slurry was incubated 30 min at 48C with gentle agitation. Lysate-bead slurry was then centrifuged at 14,000 )g at 48C for 10 min. Bead pellet was discarded and supernatant was kept for immunoprecipitation. Two hundred micrograms of lysate was added with 3 ml of primary antibody and was incubated overnight at 48C with gentle agitation. Protein AÁ coupled Sepharose beads (1 ml PBSÁBSA 1%, w/v) were prepared freshly in 400 ml lysis buffer with Halt cocktail after extensive rinsing in PBS. Seventy microliters of bead slurry was then added to each sample on ice and was agitated at 48C for 4 h. At the end of this incubation, the slurry was centrifuged and beads were washed in lysis buffer three times. Finally, with the supernatant removed, 25 ml of 2) loading buffer was added and beads were heat denatured at 958C for 5 min. This was centrifuged and supernatant was retained for electrophoresis.
Electrophoresis and Western blotting
Samples were prepared in 95% Laemmli buffer with 5% b-mercaptoethanol, denatured at 958C for 10 min and electrophoresed through a 7.5% SDS gel. Western blots were prepared using standard techniques (Stamatovic et al, 2003) . Proteins were detected using the same primary antibodies used for confocal analysis. Secondary antibodies were conjugated to horseradish peroxidase (HRP) and developed using SuperSignal West Fempto Luminol (Pierce). Images were captured with a Kodak Image Station 2000MM and Kodak Molecular Imaging Software v. 4.0.4.
Semiquantitative band densitometry was calculated by measuring mean pixel with NIH Image v 1.38. To achieve this, bands were traced manually with NIH Image and pixel intensity was measured within the selected area. Data were then corrected for GAPDH loading controls (GAPDH discrepancy across conditions: B5%).
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